Suppr超能文献

隐匿性慢性乙型肝炎病毒感染的发病机制。

Pathogenesis of occult chronic hepatitis B virus infection.

机构信息

Gastroenterology, Hospital Clinico Universitario Valladolid, Institute of endocrinology and Nutrition, Medical School, University of Valladolid, 47003 Valladolid, Spain.

出版信息

World J Gastroenterol. 2011 Mar 28;17(12):1543-8. doi: 10.3748/wjg.v17.i12.1543.

Abstract

Occult hepatitis B infection (OBI) is characterized by hepatitis B virus (HBV) DNA in serum in the absence of hepatitis B surface antigen (HBsAg) presenting HBsAg-negative and anti-HBc positive serological patterns. Occult HBV status is associated in some cases with mutant viruses undetectable by HBsAg assays; but more frequently it is due to a strong suppression of viral replication and gene expression. OBI is an entity with world-wide diffusion. The failure to detect HBsAg, despite the persistence of the viral DNA, is due in most cases to the strong suppression of viral replication and gene expression that characterizes this "occult" HBV infection; although the mechanisms responsible for suppression of HBV are not well understood. The majority of OBI cases are secondary to overt HBV infection and represent a residual low viremia level suppressed by a strong immune response together with histological derangements which occurred during acute or chronic HBV infection. Much evidence suggests that it can favour the progression of liver fibrosis and the development of hepatocellular carcinoma.

摘要

隐匿性乙型肝炎病毒感染(OBI)的特征是血清乙型肝炎病毒(HBV)DNA 存在,而乙型肝炎表面抗原(HBsAg)缺失,表现为 HBsAg 阴性和抗-HBc 阳性的血清学模式。在某些情况下,隐匿性 HBV 状态与无法通过 HBsAg 检测到的突变病毒有关;但更常见的情况是由于病毒复制和基因表达受到强烈抑制。OBI 是一种在全球范围内传播的疾病。尽管存在病毒 DNA,但未能检测到 HBsAg,这主要是由于这种“隐匿性”HBV 感染的病毒复制和基因表达受到强烈抑制所致;尽管负责抑制 HBV 的机制尚不清楚。大多数 OBI 病例继发于显性 HBV 感染,代表了一种残留的低病毒血症水平,受到强烈免疫反应的抑制,同时伴有急性或慢性 HBV 感染期间发生的组织学紊乱。大量证据表明,它可能促进肝纤维化的进展和肝细胞癌的发展。

相似文献

1
Pathogenesis of occult chronic hepatitis B virus infection.
World J Gastroenterol. 2011 Mar 28;17(12):1543-8. doi: 10.3748/wjg.v17.i12.1543.
2
Management of occult hepatitis B virus infection: an update for the clinician.
World J Gastroenterol. 2011 Mar 28;17(12):1563-8. doi: 10.3748/wjg.v17.i12.1563.
3
Diagnostic strategy for occult hepatitis B virus infection.
World J Gastroenterol. 2011 Mar 28;17(12):1553-7. doi: 10.3748/wjg.v17.i12.1553.
4
Occult hepatitis B virus infection: a complex entity with relevant clinical implications.
World J Gastroenterol. 2011 Mar 28;17(12):1529-30. doi: 10.3748/wjg.v17.i12.1529.
5
Prevalence of occult hepatitis B virus infection.
World J Gastroenterol. 2011 Mar 28;17(12):1538-42. doi: 10.3748/wjg.v17.i12.1538.
6
Clinical significance of occult hepatitis B virus infection.
World J Gastroenterol. 2011 Mar 28;17(12):1549-52. doi: 10.3748/wjg.v17.i12.1549.
7
A 2010 update on occult hepatitis B infection.
Pathol Biol (Paris). 2010 Aug;58(4):254-7. doi: 10.1016/j.patbio.2010.02.003. Epub 2010 Mar 19.
8
Influence of occult hepatitis B virus infection in chronic hepatitis C outcomes.
World J Gastroenterol. 2011 Mar 28;17(12):1558-62. doi: 10.3748/wjg.v17.i12.1558.
9
Occult HBV infection.
Semin Immunopathol. 2013 Jan;35(1):39-52. doi: 10.1007/s00281-012-0327-7. Epub 2012 Jul 26.
10
Role of occult hepatitis B virus infection in chronic hepatitis C.
World J Gastroenterol. 2015 Nov 14;21(42):11931-40. doi: 10.3748/wjg.v21.i42.11931.

引用本文的文献

1
Prevalence of hepatitis B virus core antibodies among blood donors in Nigeria: Implications for blood safety.
Afr J Lab Med. 2022 Jul 26;11(1):1434. doi: 10.4102/ajlm.v11i1.1434. eCollection 2022.
2
The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria.
Niger Med J. 2019 Jan-Feb;60(1):22-26. doi: 10.4103/nmj.NMJ_29_19.
3
Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients.
PLoS One. 2018 Oct 10;13(10):e0205356. doi: 10.1371/journal.pone.0205356. eCollection 2018.
4
Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia.
PLoS One. 2017 Oct 10;12(10):e0181643. doi: 10.1371/journal.pone.0181643. eCollection 2017.
7
Occult hepatitis B virus infection: clearance or disguise?
Clin Mol Hepatol. 2014 Sep;20(3):249-50. doi: 10.3350/cmh.2014.20.3.249. Epub 2014 Sep 25.
8
Occult hepatitis B virus and hepatocellular carcinoma.
World J Gastroenterol. 2014 May 28;20(20):5951-61. doi: 10.3748/wjg.v20.i20.5951.
9
Potential mutations associated with occult hepatitis B virus status.
Hepat Mon. 2014 May 3;14(5):e15275. doi: 10.5812/hepatmon.15275. eCollection 2014 May.
10
Occult HBV infection: a faceless enemy in liver cancer development.
Viruses. 2014 Apr 8;6(4):1590-611. doi: 10.3390/v6041590.

本文引用的文献

1
Transfusion-transmitted hepatitis B virus infection.
J Hepatol. 2009 Oct;51(4):798-809. doi: 10.1016/j.jhep.2009.05.020. Epub 2009 Jun 10.
2
Persistent occult hepatitis B virus infection: experimental findings and clinical implications.
World J Gastroenterol. 2007 Nov 21;13(43):5682-6. doi: 10.3748/wjg.v13.i43.5682.
4
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.
Br J Haematol. 2007 Mar;136(5):699-712. doi: 10.1111/j.1365-2141.2006.06465.x.
6
Chronic hepatitis B.
Hepatology. 2007 Feb;45(2):507-39. doi: 10.1002/hep.21513.
7
Occult hepatitis B and infliximab-induced HBV reactivation.
Inflamm Bowel Dis. 2007 Apr;13(4):508-9. doi: 10.1002/ibd.20035.
8
Occult hepatitis B virus infection.
J Hepatol. 2007 Jan;46(1):160-70. doi: 10.1016/j.jhep.2006.10.007. Epub 2006 Nov 7.
9
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
J Hepatol. 2006 Oct;45(4):529-38. doi: 10.1016/j.jhep.2006.05.013. Epub 2006 Jun 23.
10
Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.
J Clin Virol. 2006 May;36 Suppl 1:S33-44. doi: 10.1016/s1386-6532(06)80007-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验